NEW YORK (GenomeWeb) – The European Research Council (ERC) has awarded a research team €2.5 million ($2.8 million) to study the evolution of silent mutations and their potential use in diagnostics and gene therapy.

So-called silent, or synonymous, mutations change the sequence of a gene but not the protein it encodes. Although previously thought to have no biological effect, new data suggest that silent mutations may be associated with disease states.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.